| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/02/2000 | WO2000031265A1 Urotensins ii of mammals and their uses |
| 06/02/2000 | WO2000031139A1 Peptide inhibitor of browman-birk type |
| 06/02/2000 | WO2000031129A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease |
| 06/02/2000 | WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 06/02/2000 | WO2000031121A1 Recombinant factor viii binding peptides |
| 06/02/2000 | WO2000014542A3 Diagnostic method for detecting disturbances of the pancreas |
| 06/02/2000 | WO2000012587A3 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 06/02/2000 | CA2352606A1 Urotensins ii of mammals and their uses |
| 06/02/2000 | CA2352493A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease |
| 06/02/2000 | CA2351893A1 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | CA2351166A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide |
| 06/02/2000 | CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 05/31/2000 | EP1004595A2 Lytic and proliferative peptides and their use as pharmaceutic and phytopharmaceutic agents |
| 05/31/2000 | EP1004322A2 Technetium-99m labeled peptides for thrombus imaging |
| 05/31/2000 | EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 05/31/2000 | EP1003775A2 Hepatitis c inhibitor peptides |
| 05/31/2000 | EP1003774A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 05/31/2000 | EP1003773A1 Ctl epitopes from ebv |
| 05/31/2000 | EP1003771A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 05/31/2000 | EP1003542A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP0944650B1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 05/31/2000 | EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/31/2000 | CN1255143A Novel strain of bacillus for controlling plant diseases and corn rootworm |
| 05/31/2000 | CN1255044A Orally active fraction of momordica charactia, active peptides thereof, and their use in the treatment of diabetes |
| 05/31/2000 | CN1254718A Active peptide |
| 05/30/2000 | US6069242 Mixture of pharmaceutically acceptable carrier and antisense nucleic acid; for diagnosis, imaging, anticarcinogenic agents, antitumor agents |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm |
| 05/30/2000 | CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals |
| 05/25/2000 | WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy |
| 05/25/2000 | WO2000029427A2 Antennapedia homeodomain helix 3 derived translocation vectors |
| 05/25/2000 | WO2000029426A1 Compositions and methods for controlling plant pests |
| 05/25/2000 | WO2000029010A1 Mimetic insect allatostatin analogs for insect control |
| 05/25/2000 | WO2000029009A1 Peptides having anti-cancer and anti-inflammatory activity |
| 05/25/2000 | WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 05/25/2000 | CA2351622A1 Polypeptide |
| 05/25/2000 | CA2350919A1 Antennapedia homeodomain helix 3 derived translocation vectors |
| 05/25/2000 | CA2350782A1 Compositions and methods for controlling plant pests |
| 05/24/2000 | EP1002861A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/24/2000 | EP1002547A1 Hydrosoluble hedgehog protein in ionic complex and pharmaceutical use thereof |
| 05/24/2000 | EP1002543A1 Pharmaceutical compositions for the therapy of glioma or prostate cell proliferative disorders containing cyclic rgd compounds |
| 05/24/2000 | EP1001986A2 Pharmaceuticals for modulating hormone responsiveness |
| 05/24/2000 | EP1001979A1 Cyclic azapeptides with angiogenic effect |
| 05/24/2000 | EP1001978A1 Angiotensin derivatives |
| 05/24/2000 | EP1001977A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
| 05/24/2000 | EP1001976A2 Peptides having potassium channel opener activity |
| 05/24/2000 | EP0720620B1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 05/24/2000 | EP0687270B1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 05/24/2000 | EP0652764B1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 05/24/2000 | EP0529031B1 Improved inhibitors of thrombin |
| 05/24/2000 | CN1254383A Fluorogenic protease substrates based on dye-dimerization |
| 05/24/2000 | CN1254379A Methods of production of amidated peptide through use of fusion protein |
| 05/24/2000 | CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase |
| 05/24/2000 | CN1254374A Inhibitors of cellulolytic, xylanolytic and 'beta'-glucanolytic enzymes |
| 05/24/2000 | CN1253953A Peptide immunogen, vaccine made of one for curing allergic reaction and its preparation method |
| 05/24/2000 | CN1052731C Compounds with growth hormone releasing properties |
| 05/24/2000 | CN1052730C Compounds with growth hormone releasing properties |
| 05/23/2000 | US6066622 Immunomodulating peptides and methods of use |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066462 Quantitation of individual protein kinase activity |
| 05/23/2000 | US6066320 Isolating antiserum with nerve cells presenting anti-prion protein |
| 05/23/2000 | CA2072125C Design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 05/23/2000 | CA2066997C Antimicrobial peptide and antimicrobial agent |
| 05/18/2000 | WO2000027880A2 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | WO2000027866A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
| 05/18/2000 | WO2000027792A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | WO2000009553A3 Antimicrobial peptides isolated from the skin of american frogs |
| 05/18/2000 | WO2000002916B1 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY |
| 05/18/2000 | WO1999061467A3 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 05/18/2000 | CA2350915A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
| 05/18/2000 | CA2348763A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | CA2348308A1 Rantes-derived peptides with anti-hiv activity |
| 05/17/2000 | EP1001024A2 Protein encoded by the trkB proto-oncogene, used in assay systems for neurothophin activity |
| 05/17/2000 | EP1000177A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0620825B1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063758 Substance P-Saporin (SP-SAP) conjugates and methods of use thereof |
| 05/16/2000 | US6063625 Regulated transcription of targeted genes and other biological events |
| 05/16/2000 | CA2084060C Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 05/12/2000 | CA2288680A1 Modulation of cell proliferative disorders by cyclic rgd |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026344A1 Peptides with enhanced stability to protease degradation |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000025814A2 Component for vaccine against serogroup b meningococci |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/10/2000 | EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/10/2000 | EP0999219A2 Novel heparin binding peptides |
| 05/10/2000 | EP0998494A1 Pompilid wasp-derived neuropeptides |
| 05/10/2000 | EP0998493A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 05/10/2000 | EP0998489A1 A NOVEL ANTIMICROBIAL PEPTIDE ISOLATED FROM $i(PARASILURUS ASOTUS) AND ITS USES |
| 05/10/2000 | EP0998299A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/10/2000 | CN1252808A Antipathogenic synthetic piptides and compositions comprising them |
| 05/10/2000 | CN1252806A Dolastatin-15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus |
| 05/10/2000 | CN1252728A Dolastatin-15 derivatives in combination with taxanes |